Unselected preoperative coagulation testing is known to have low positive yield. However, no study has specifically evaluated neurosurgical patients. A retrospective study of 1211 patients having neurosurgery over a one-year period was therefore conducted. Preoperative test results (activated partial thromboplastin time [aPTT], prothrombin time [PT] and platelet count) and historical factors indicating a potential bleeding tendency were recorded. Abnormality was defined as a test result outside the normal range for our laboratory. Seventeen per cent of all test results were abnormal. However, if abnormality was redefined as a test result indicating potential bleeding tendency (low platelet count, prolonged aPTT and/or PT), only 7.2% of results were abnormal. Many patients had factors on history indicating a potential bleeding tendency, but only a prolonged aPTT, cranial surgery and the use of anti-hypertensive and anaesthetic drugs preoperatively predicted postoperative bleeding. Prolonged aPTT was predictable on history in most patients. We conclude that routine screening of all preoperative neurosurgical patients in our hospital is unnecessary.
Bleeding is a rare yet feared complication of neurosurgery. Preoperative coagulation tests and platelet counts are routinely performed in neurosurgical patients in our hospital in an effort to diagnose occult haemostatic disorders. Such routine testing is costly and time-consuming, and may produce a significant number of false positive results. In fact, routine screening in healthy preoperative patients was reported to be of limited benefit 1 .
No previous studies have specifically evaluated the neurosurgical population. These patients may have haemostatic abnormalities associated with their surgical disease and the consequences of postoperative bleeding may be serious. Therefore, we retrospectively reviewed our neurosurgical practice to determine the frequency of abnormal coagulation studies and platelet counts and define the clinical factors which predict abnormal test results and postoperative bleeding.
MATERIALS AND METHODS
A retrospective study was undertaken of all neurosurgical operations performed during a continuous 12-month period at the Royal Melbourne Hospital. Patients were identified from the operating theatre database. The relevant laboratory tests were defined as those undertaken closest to and before the operation. Each patient's medical record was reviewed and the following information, potentially relevant to haemostasis, was recorded: history of coagulation disorders, bleeding or bruising tendency, family history of bleeding disorders, renal failure, disseminated malignancy, major trauma, alcohol abuse, liver disease, malabsorption, postoperative bleeding and prescribed medication taken preoperatively. Prescribed medications were grouped into classes. In addition, drugs known to cause thrombocytopenia were grouped together 2 .
Haemostatic screening comprised the activated partial thromboplastin time (aPTT), the prothrombin time (PT) and the platelet count. All tests were performed in the Haematology laboratories of the Royal Melbourne Hospital. The normal reference ranges of the laboratory tests were used to define an abnormal result.
Operations were divided into three groups according to type: "cranial" (eg., craniotomy), "spinal" (eg., lumbar laminectomy) and "peripheral or other" (eg., carpal tunnel decompression). Patients were considered to have abnormal postoperative bleeding, but not necessarily a bleeding tendency, if they required CT scanning or further surgery to confirm and treat bleeding, or if bleeding was documented as excessive in the surgical progress notes.
Patient and perioperative data are presented as mean and standard deviation (SD) or number (%). The association between these factors and postoperative bleeding was calculated using χ 2 with Yates' correction and odds ratios (OR, 95% confidence limits [95% CI]). Significant univariate associations were entered into logistic regression models in order to identify independent predictors. All analyses were performed using SPSS for Windows V 8.0. A P value of less than 0.05 was considered statistically significant.
RESULTS
During the twelve-month study period, 1211 neurosurgical operations were performed. Patients were aged 53 (17) years and 48% were female. Fifty-six per cent of patients underwent cranial surgery, 33% underwent spinal surgery and 11% underwent peripheral and other surgery. Coagulation tests and platelet counts were performed in 76% of patients (80% cranial; 83% spinal and 24% peripheral and other surgery).
In this study, 17% of all tests were either above or below the normal range for our laboratory (Table 1) . However, if abnormality was redefined as a test result indicating potential bleeding tendency (low platelet count, prolonged aPTT and/or PT), only 7.2% of results could be considered abnormal.
Many patients had conditions on history which indicated a potential bleeding tendency ( Table 2 ). In addition, many patients were taking medications with the potential to cause thrombocytopaenia (drugs per patient:
Factors predicting postoperative bleeding were a prolonged preoperative aPTT, cranial surgery, the use of "other hypertensive drugs" and the use of "other drugs" (Table 3) . Factors predicting a prolonged aPTT were a bleeding or bruising history and the use of antiemetics (Table 4 ). No factors were identified which predicted either a prolonged PT or low platelet count in this population. Prolonged PT and low platelet count were not predictive of postoperative bleeding in our study.
The incidence of a shortened aPTT was 26%. Factors predicting a shortened aPTT in the multivariate model were older age, adrenocortical steroid use and H 2 -receptor antagonist use. Female patients B. SCHRAMM, K. LESLIE ET AL and those having peripheral or other surgery were less likely to have a shortened preoperative aPTT ( Table 5 ).
DISCUSSION
Preoperative coagulation testing has low positive predictive value. In fact, several commentators have advised that routine preoperative testing is unnecessary 3, 4 . Despite this, coagulation studies are ordered routinely as part of the preoperative evaluation of neurosurgical patients in our hospital. Reasons for this practice include: 1) lack of evidence that omitting coagulation tests in neurosurgical patients is safe; 2) fear of the consequences of postoperative bleeding following neurosurgery; and 3) suspicion that coagulation disorders and thrombocytopaenia may occur more frequently in neurosurgical patients. Patients undergoing craniotomy, in particular, may have a higher incidence of bleeding disorders which are either congenital or secondary to drugs (e.g., warfarin), liver disease, malignancy or major trauma. We therefore thought it necessary to define the incidence of abnormal coagulation studies, thrombocytopaenia and historical predictors of bleeding in our neurosurgical population.
Our results indicate a similar incidence of abnormal test results to other studies screening different adult patient populations. For example, in a study of general surgical and gynaecological patients, 38 of 750 patients (5%) had a prolonged PT or aPTT 5 . Another study in elective general surgical patients reported a 4.1% incidence of prolonged PT, aPTT or bleeding time, or a low platelet count 6 . Finally, 10% of patients in a study of fibreoptic bronchoscopy returned abnormal results 7 . All these authors concluded that screening coagulation tests need not be done preoperatively.
The raison d'être of preoperative haemostatic 
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testing in neurosurgical patients is to prevent intraoperative and postoperative bleeding. The only test predictive of postoperative bleeding in our analysis was a prolonged aPTT. A prolonged aPTT may indicate an intrinsic coagulation factor deficiency, coagulation factor inhibition or the presence of heparin, or may result from faulty collection and storage of the sample 8 . Most of the 14 patients with a prolonged preoperative aPTT and significant postoperative bleeding had a risk factor for that test result and outcome that could be identified by their clinical history alone.
The odds of postoperative bleeding were also greater in patients undergoing cranial surgery and in those administered antihypertensive or anaesthetic medication preoperatively. These drugs are surrogate markers for critically ill patients with a greater risk of bleeding. Not all patients with postoperative bleeding had a risk factor detected, and postoperative bleeding may have arisen from surgical causes. We conclude that routine screening of all preoperative neurosurgical patients in our hospital is unnecessary.
The most common test abnormality in this study was a shortened aPTT, which is not of clinical relevance in predicting a bleeding risk. The aPTT may be shortened if: 1) venepuncture is slow or difficult, activating the coagulation cascade; 2) an incorrect volume of blood is added to the collection tube; or 3) there is delay in mixing with citrate anticoagulant, suboptimal specimen storage or transport 8 . When we searched for historical factors contributing to a shortened aPTT, we found that numerous factors had a statistical association, but the clinical significance of these associations is uncertain.
There are several potential problems with this study, which may have resulted from the retrospective study design. Firstly, using our study methods, we cannot determine how many elective patients, if any, failed to proceed to surgery because of abnormal coagulation studies. Secondly, patients taking anticoagulants may have received protamine, vitamin K or fresh frozen plasma before coagulation tests were taken. Finally, the incidence of postoperative bleeding was probably underestimated, although severe bleeding should have been recorded using our detection method.
Defining "Abnormality" Usefully
The distributions of coagulation and platelet test results for "normal" and "abnormal" patients overlap significantly (i.e., the distribution is not continuous and bimodal). If "abnormality" is defined statistically, as it was in this study, by a result two standard devia-tions from the mean of a reference population, then a substantial number of "normal" people will be classified as "abnormal". In addition, results not associated with bleeding risk, such as a shortened aPTT, will also be classified as "abnormal". Clearly, another definition of abnormality would be more serviceable 9 .
A preferable definition of "abnormality" is a test result which is regularly associated with disease 9 . When we redefined "abnormality" as a test result indicating a potential bleeding tendency (a prolonged aPTT or PT or a low platelet count), the incidence of abnormality decreased from 17% to 7.2%. However, this definition still includes a number of "normal" patients who happen to post a high result on the day of testing. Retesting usually results in the report of a normal result.
In order to further refine the classification of abnormality, some centres have developed the concept of "action limits". Action limits are a selected reference range outside which surgery should be "delayed or anaesthetic management modified" and the reason for the abnormal result investigated 10 . In view of the high number of marginally abnormal test results in our study, action limits would make interpreting coagulation test results easier and would provide triggers for medical staff to respond to potentially hazardous results and seek appropriate haematological consultation.
In summary, 17% of all preoperative coagulation and platelet count results were abnormal in this study. If abnormality was redefined as test results indicating a potential bleeding tendency (low platelet count, prolonged aPTT and/or PT), only 7.2% of results were abnormal. We conclude that routine screening of all preoperative neurosurgical patients in our hospital is unnecessary. If testing was restricted to patients with a potential bleeding tendency on history, then only approximately 17% of patients would need to be tested. We recommend the use of "action limits" to guide management after an abnormal test.
